ESR1 and breast cancer: HER2 (negative to ER and PR, positive to HER2) and basal-like (negative for all three receptors and, consequently, also known as triple negative, TN) subtypes have the worst prognosis and the latter is often associated with lymph node involvement [16] and accounts for a large portion of breast cancer deaths after diagnosis [17].